Post-Orgasmic Illness Syndrome Successfully Treated with Omalizumab: A Case Report.

McLean-Tooke, Andrew; Klinken, Elizabeth

McLean-Tooke, Andrew; Klinken, Elizabeth.

Afiliación

McLean-Tooke A; Department of Immunology, Sir Charles Gairdner Hospital, Perth, Australia.
Klinken E; Department of Immunology, Sir Charles Gairdner Hospital, Perth, Australia.

J Sex Marital Ther ; 50(3): 342-345, 2024.

Article en En | MEDLINE | ID: mdl-38124662

ABSTRACT

ABSTRACT

Post-orgasmic illness syndrome (POIS) is a rare disorder associated with a debilitating symptoms post-ejaculation associated with significant impairment in quality of life. The mechanism of the disease is unclear, but hypersensitivity to semen and/or seminal fluid has been postulated. We present a case of POIS successfully treated with omalizumab suggesting a possible role for this therapy in POIS treatment and management.

Asunto(s)

Eyaculación; Omalizumab; Masculino; Humanos; Omalizumab/uso terapéutico; Calidad de Vida; Orgasmo; Semen; Síndrome

Palabras clave

Post-orgasmic illness syndrome; ejaculation; omalizumab; orgasm disorder

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eyaculación / Omalizumab Límite: Humans / Male Idioma: En Revista: J Sex Marital Ther Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google